EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.

被引：0

|

作者：

Raphael, G.

Taveras, H.

Iverson, H.

O'Brien, C.

Miller, D.

机构：

来源：

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2014年 / 113卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

P74

引用

收藏

页码：A45 / A46

页数：2

相关论文

共 50 条

[31] Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate
Wardlaw, A
Larivee, P
Eller, J
Cockcroft, DW
Ghaly, L
Harris, AG
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (01) : 49 - 55
[32] Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir® Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies
Kerwin, Edward M.
Taveras, Herminia
Iverson, Harald
Wayne, Denise
Shah, Tushar
Lepore, Mark S.
Miller, David S.
CLINICAL DRUG INVESTIGATION, 2016, 36 (01) : 55 - 65
[33] Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir® Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies
Edward M. Kerwin
Herminia Taveras
Harald Iverson
Denise Wayne
Tushar Shah
Mark S. Lepore
David S. Miller
Clinical Drug Investigation, 2016, 36 : 55 - 65
[34] The pharmacokinetics, safety, and tolerability of single, high-strength doses of fluticasone propionate and fluticasone propionate/salmeterol delivered via a novel multidose dry powder inhaler in adolescents and adults with persistent asthma
Nugent, Courtney
Yiu, Gloria
Song, Sharon
Caracta, Cynthia
JOURNAL OF ASTHMA, 2018, 55 (08) : 898 - 906
[35] Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma
Galant, SP
van Bavel, J
Finn, A
Gross, G
Pleskow, W
Brown, A
Hamedani, AG
Harding, SM
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (03) : 273 - 280
[36] Effectiveness of budesonide administered via dry-powder inhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler for adults with persistent asthma in managed care settings
Weiss, KB
Liljas, B
Schoenwetter, W
Schatz, M
Luce, BR
CLINICAL THERAPEUTICS, 2004, 26 (01) : 102 - 114
[37] Real-world Study Characterizing Patients Prior to Receiving Albuterol Multidose Dry Powder Inhaler or Short-acting β2-Agonist Via Pressurized Metered-Dose Inhalers for Asthma and COPD in the United States
Bensch, Gregory
Parker, Emily D.
Ariely, Rinat
Stoyanov, Stanislav
Ramakrishnan, Karthik
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB208 - AB208
[38] Efficacy and Safety of Mometasone Furoate and Formoterol (MF/F) 200/10 μg Twice-Daily Administered via a Pressurized Metered-Dose Inhaler in Subjects 12 Years of Age and Older With Moderate-to-Severe Asthma
Nathan, R. A.
Pearlman, D.
Nolte, H.
Nayak, A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
[39] EFFICACY OF BUDESONIDE/FORMOTEROL PRESSURIZED METERED-DOSE INHALER VERSUS BUDESONIDE ALONE IN CHILDREN (6-<12 YEARS) WITH ASTHMA
Pearlman, D.
Eckerwall, G.
McLaren, J.
Lamarca, R.
Puu, M.
Jorup, C.
Sandin, K.
Lanz, M.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S8 - S8
[40] A Double-Blind Placebo-Controlled, Multicenter, Cross-Over, Dose-Ranging Study to Compare the Efficacy and Safety of Albuterol Spiromax and Proair HFA in Adult and Adolescent Patients Ages 12 and Older with Persistent Asthma
Kerwin, Edward M.
Taveras, Herminia
Iverson, Harald
Wayne, Denise
Shah, Tushar
Lepore, Mark S.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB5 - AB5

← 1 2 3 4 5 →